Navigation Links
Protein Sciences Corporation Appoints New Board of Directors
Date:4/30/2009

Production of a Swine Flu Vaccine in a Few Weeks

MERIDEN, Conn., April 30 /PRNewswire/ -- Protein Sciences Corporation (PSC), a privately-owned biopharmaceutical company based in Meriden, CT, announced today that stockholders elected a new slate of members to the Company's Board of Directors at the 2009 Annual Meeting, held on April 28, 2009. Those Directors are:

  • Daniel D. Adams, who has been CEO since July 1996, President since 1998 and a Director since May 1996. Mr. Adams also was named Chairman of the Board of Directors.
  • Drs. Manon M.J. Cox, MBA, who is Chief Operating Officer.
  • Anders Essen-Moller, who is Chairman and founder of Sweden-based Diamyd Medical AB, which is listed on NASDAQ OMX in Stockholm, Sweden.
  • Donna R. Galluzzo, PhD., R.D., President and CEO of Homecare Management Strategies, Inc. and its division, Omni Medical Billing Plus.
  • Robert B. Georgen, Chairman and CEO of Blyth, Inc., who has been a Director at PSC, since November 1995. He is also Managing Partner of The Ropart Group, a private equity firm.
  • Howard E. Levine, PhD., who is Founder, President and Principal Consultant of BioProcess Technology Consultants, Inc.
  • William H. Narwold, who previously served as Chairman of the Board, has been a Director since March 1992. He is a Managing Member of the law firm of Motley Rice LLC.

About PSC. PSC is a biopharmaceutical company, whose mission it is to save lives and improve health by effectively responding to our changing world with innovative vaccines and biopharmaceuticals. PSC uses recombinant DNA technology to make novel human and veterinary prophylactic and therapeutic vaccines and diagnostics. The active ingredients in all of the firm's products are recombinant proteins that are manufactured, using its patented protein expressi
'/>"/>

SOURCE Protein Sciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Draining away brains toxic protein to stop Alzheimers
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
4. Emory researchers identify signaling protein for multiple myeloma
5. Human C-reactive protein regulates myeloma tumor cell growth and survival
6. Lowering Blood Protein Wont Help Kidney Patients
7. Blood protein detects lung cancer, even at earliest stage
8. Natural Protein Could Help Spot, Treat Liver Cancer
9. Heat shock proteins are co-opted for cancer
10. How adhesive protein causes malaria
11. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2
...d in the August 27 Advance Online issue of the jou...g ovarian development have been unraveled by// sci... are abound in biology and are not well understood... it needs to regenerate itself. When such loops de...
...beekeepers to produce sugar-free herbal honey, the...eeping system in Himachal Pradesh.// The Natio...ping boxes along with the bees to the state, to be...roduce sugar free honey. The plant is also conside...
...ar inaugurated the Tripura Medical College Sunday ...lege-cum-hospital in India's northeastern// region...al Educational Net (GENET) in collaboration with t...m-managing director, Universal Empire Group (UEG),...
...msay has recommended that Canadians suffering from... (epinephrine) or the Twinject, which// provides a...o avoid potentially deadly situations. He has al...n into death of retired doctor, Pierre Drolet, 61,...
...ave reported finding H5N1 virus in a small duck fa...// An animal health official from Thach Ph...ed laboratory confirmation that the ducks had the ...us. The official said that no one in nearby ...
...deration (JEF) has confirmed that 22 organizations...eed out the stigma and discrimination// associated...ing up with the Health and labor companies, the em... national business council is also on the anvil, m...
Other Medicine News:Health News:Feedback Loop Governing Ovarian Development Unraveled 2Health News:Feedback Loop Governing Ovarian Development Unraveled 3Health News:Feedback Loop Governing Ovarian Development Unraveled 4
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application o
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3China Biotics Inc Announces Closing of Public Offering of Common Stock 58860 1China Biotics Inc Announces Closing of Public Offering of Common Stock 58860 2China Biotics Inc Announces Closing of Public Offering of Common Stock 58860 3VIDEO from Medialink and CIGNA 3A Dont Stress Out Over Stress Some of it is Good for You 58857 1VIDEO from Medialink and CIGNA 3A Dont Stress Out Over Stress Some of it is Good for You 58857 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 1Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 3Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 4
...ngs Published in Blood Highlight Millennium Leader... the Role of VELCADE as,Foundation of Therapy in B...GE, Mass., April 17, 2007 /PRNewswire-FirstCall/ -...ood show that a,team of researchers led by Millenn...s which may lead to identifying multiple,myeloma p...
...nation Therapy Significantly Decreased Tumor Blood...umors -, LOS ANGELES and TUSTIN, Calif., April 17,...uticals, Inc. , a,clinical stage biopharmaceutical... for the treatment of cancer and hepatitis C,virus... data,presented at the Centennial Annual Meeting o...
Other Medicine Technology:Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 2Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 3Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 4Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 5Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 6Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 2Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 3Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 5
Finnpipette Fixed Volume, 20ul
Pipetman F1000
Finnpipette Focus Fixed Volume, 1ul
Finnpipette Fixed Volume, 2ul
Medicine Products: